COVID-19
A Lesson in Culture
On the 17th of May, I attended the Bio Integrates event – hosted by Life Science Integrates – at the Leonardo Royal Hotel in...
How to navigate IR35 to secure top interim talent
In April 2021, the UK Government extended the off-payroll working (IR35) rules to the private sector; now affecting any medium and large organisations looking...
The future of pharma working practices
The COVID-19 pandemic has led to fundamental changes in the way we work. The sudden shift to remote working has created an unprecedented opportunity...
Recognising and celebrating Extraordinary Connections at our 40th Anniversary Party
On Thursday 9th September, The RSA Group celebrated its 40-year anniversary with a special event at The Garden Museum in London. The venue was...
Should people move to jobs or should jobs move to people?
When a talented person is hired by a life sciences organisation, where should they work? This isn’t a story about the pandemic, although undoubtedly...
James Camp joins The RSA Group as an intern
The RSA Group is delighted to announce that James Camp is joining the UK arm of the group as part of its internship programme...
Inspiring Leaders | Steve Harbin
Steve Harbin believes it takes good science, good people and good business to develop and grow a leading biotech. He joined Oncorus Inc. as...
What will we need from life sciences leaders in 2021?
As a follow up to my recent blogs, I would like to share some further reflections about what Executive Leaders and Board members in...
Inspiring Leaders | Shiva Dustdar
We were honoured to speak to Shiva Dustdar who is Head of Division, Innovation Finance Advisory for the European Investment Bank. In this blog...
Further reflections from a Headhunter in life sciences who is (still) a realistic optimist
We all need a RQ (Reflective Intelligence Quotient) – we already have embraced IQ and EQ or ??? Having more time (no commute into...
Medical research charity Boards need to adapt to the new world or risk failure – Volume 2
In volume 1 of this blog, I looked at the tension caused by the growing demands on medical research charities and their heightened financial...
Medical research charity Boards need to adapt to the new world or risk failure – Volume 1
As we come out of the first wave of the Covid-19 pandemic, the issues affecting the Boards of medical research charities are, in many...
What should pharma companies learn from the pandemic? Volume 2
Accelerated Evolution | The “New Normal” For the Pharma industry, Covid-19 has been a catalyst like no other. Even HIV in the 1980s wasn’t...
What should pharma companies learn from the pandemic? Volume 1
Now is the opportunity for leaders to create essential change
I’m often asked: “How are the best leaders behaving?” I observe that quicker decision-making, simplicity...
Key Learnings from the Coronavirus Challenge and innovating for a sustainable future
The life science sector is under extreme pressure to meet the global need for better, faster therapies to combat COVID-19 and The BIA is...
Interim managers can help when international travel is restricted
As the world faces an unprecedented global shutdown amid the COVID-19 pandemic, for life sciences companies it’s in the interests of everyone, not least...
IR35 postponement makes Interim Executives an option once again
This week’s government decision to postpone the implementation of the Off-Payroll Tax (IR35) to the private sector until April 2021 is a welcome announcement...
Considerations for leaders: managing teams remotely
Following last week’s announcement by the World Health Organisation that the spread of Covid-19 has officially reached ‘pandemic’ status, more and more companies are...